The Cochrane database of systematic reviews··
Calcium supplements for people who are overweight or obese
Updated
Abstract
Calcium supplementation may result in a small reduction in body mass index (BMI) of -0.18 kg/m.
- Low-certainty evidence suggests little to no difference in body weight with calcium supplementation compared to placebo.
- Calcium supplementation may lead to a modest reduction in waist circumference by -0.51 cm.
- There is low-certainty evidence for a small reduction in body fat mass of -0.34 kg with calcium supplementation.
- Most studies included in the analysis were short-term, lasting less than six months, and primarily involved women.
- Concerns regarding risk of bias and statistical variability downgraded the certainty of the evidence.
Simplified
BACKGROUND: Obesity is a major health problem worldwide as it can lead to high blood pressure, heart disease, stroke, diabetes, and insulin resistance. The prevalence of overweight and obesity is increasing worldwide across different age groups. There is evidence of an inverse relationship between calcium intake and body weight. The clinical relevance of a small reduction in body weight has been questioned. However, at a population level, a small effect could mitigate the observed global trends.
OBJECTIVES: To assess the effects of calcium supplementation on weight loss in individuals living with overweight or obesity.
SEARCH METHODS: We searched CENTRAL, MEDLINE, Embase, LILACS (Latin American and Caribbean Health Science Information database), and two clinical trials registries. The date of the last search of all databases (except Embase) was 10 May 2023. No language restrictions were applied.
SELECTION CRITERIA: We included randomised controlled trials evaluating the effect of calcium in participants with overweight or obesity of any age or gender. We excluded studies in participants with absorption problems. We included studies of any dose with a minimum duration of two months. We included the following comparisons: calcium supplementation versus placebo, calcium-fortified food or beverage versus placebo, or calcium-fortified food or beverage versus non-calcium-fortified food or beverage. We excluded studies that evaluated the effect of calcium and vitamin D or mixed minerals compared to placebo.
DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. Our primary outcomes were body weight, health-related quality of life, and adverse events. Our secondary outcomes were anthropometric measures other than body weight, all-cause mortality, and morbidity.
MAIN RESULTS: We found 18 studies that evaluated the effect of calcium compared to placebo or control, with a total of 1873 randomised participants (950 participants in the calcium supplementation groups and 923 in the control groups). All included studies gave oral calcium supplementation as the intervention. We did not find any studies evaluating calcium-fortified foods. We excluded 38 studies, identified four ongoing studies, and listed one study as 'awaiting classification'. Sixteen studies compared calcium supplementation to placebo; two studies compared different doses of calcium supplementation. Doses ranged from very low (0.162 g of calcium/day) to high (1.5 g of calcium/day). Most studies were performed in the USA and Iran, lasted less than six months, and included only women. Low-certainty evidence suggests that calcium supplementation compared to placebo or control may result in little to no difference in body weight (mean difference (MD) -0.15 kg, 95% confidence interval (CI) -0.55 to 0.24; P = 0.45, I= 46%; 17 studies, 1317 participants; low-certainty evidence). We downgraded the certainty of the evidence by two levels for risk of bias and heterogeneity. None of the included studies reported health-related quality of life, all-cause mortality, or morbidity/complications as outcomes. Only five studies assessed or reported adverse events. Low-certainty evidence suggests a low frequency of adverse events, with no clear difference between intervention and control groups. Moderate-certainty evidence shows that calcium supplementation compared to placebo or control probably results in a small reduction in body mass index (BMI) (MD -0.18 kg/m,95% CI -0.22 to -0.13; P < 0.001, I= 0%; 9 studies, 731 participants) and waist circumference (MD -0.51 cm, 95% CI -0.72 to -0.29; P < 0.001, I= 0%; 6 studies, 273 participants). Low-certainty evidence suggests that calcium supplementation compared to placebo or control may result in a small reduction in body fat mass (MD -0.34 kg, 95% CI -0.73 to 0.05; P < 0.001, I= 97%; 12 studies, 812 participants). 2 2 2 2 2
AUTHORS' CONCLUSIONS: Calcium supplementation for eight weeks to 24 months may result in little to no difference in body weight in people with overweight or obesity. The current evidence is of low certainty, due to concerns regarding risk of bias and statistical heterogeneity. We found that the degree of heterogeneity might be partly explained by calcium dosage, the presence or absence of a co-intervention, and whether an intention-to-treat analysis was pursued. While our analyses suggest that calcium supplementation may result in a small reduction in BMI, waist circumference, and fat mass, this evidence is of low to moderate certainty. Future studies could investigate the effect of calcium supplementation on lean body mass to explore if there is a change in body composition.
Related papers
Nov '22
Folic acid supplements and malaria risk and severity in people using antifolate malaria drugs in affected areas
cited by 28 papers
systematic review
Jun '23
Low glycemic index versus low glycemic load diets for people who are overweight or obese
cited by 4 papers
research support, non-u.s. gov't
Feb '24
Smartphone health programs for teens and adults with overweight or obesity
cited by 23 papers
systematic review
Mar '21
Weight Loss Treatments for Overweight or Obese People with Chronic Kidney Disease
cited by 19 papers
systematic review
Jul '25
Using gut bacteria to help manage obesity in children and teenagers up to 19 years old
cited by 1 paper
systematic review
Dec '25
Calcium supplements during pregnancy to help prevent high blood pressure and related problems
cited by 4 papers
systematic review
Jul '24
Vitamin D supplements for pregnant women
cited by 18 papers
systematic review
Jul '19
Vitamin D supplements for pregnant women
cited by 128 papers
systematic review
May '19
Adding Vitamin A to Common Foods to Prevent Vitamin A Deficiency
cited by 32 papers
systematic review
Dec '17
Ways to help health workers and care systems support weight loss in children and adults with overweight or obesity
cited by 26 papers
systematic review